Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Background: Intravenous immunoglobulin (IVIg) is efficient and one of very few treatment options for patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). However, finding the optimal dose of IVIg for individual CIDP patients remains challenging. The dose of IVIg needs to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Feyen, Ludger, Schaub, Christina, Zimmermann, Julian, Nitsch, Louisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058913/
https://www.ncbi.nlm.nih.gov/pubmed/36976670
http://dx.doi.org/10.3390/neurolint15010027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058913/
https://www.ncbi.nlm.nih.gov/pubmed/36976670
http://dx.doi.org/10.3390/neurolint15010027

Ejemplares similares